InvestorsHub Logo
Followers 2
Posts 34
Boards Moderated 1
Alias Born 07/14/2015

Re: None

Tuesday, 06/13/2017 4:22:24 PM

Tuesday, June 13, 2017 4:22:24 PM

Post# of 3562
How profitability is the biosimilar business?

Will be interesting to hear updates on how the Teva business case will change when the Strategic Associate to the Generics President & CEO presents on the biosimilars business case this September in London.

Details on Biosimilars & Biobetters 2017 can be found at http://www.biosimilars-europe.com/inhu
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TEVA News